Biotech Series C Investors & VC Firms
600 firms in this list, with a median first check of $1M. 112 of them lead rounds. Generated from verified public data and updated continuously.
Andreessen Horowitz
Menlo ParkSeed–Late Stage$500K – $50M
130 people
Andera Partners
ParisPre-Seed–Late Stage
136 people
F-Prime Capital Partners
CambridgePre-Seed–Late Stage$3M – $10M
104 people
Bessemer Venture Partners
Redwood CitySeed–Late Stage$5M – $100M
58 people
Khosla Ventures
Menlo ParkPre-Seed–Late Stage$5K – $50M
56 people
OrbiMed
New YorkPre-Seed–Late Stage$1M – $75M
126 people
DCVC (Data Collective)
Palo AltoPre-Seed–Late Stage$5M – $25M
66 people
GV (Google Ventures)
Mountain ViewSeed–Late Stage$250K – $50M
72 people
Sequoia Capital
Menlo ParkPre-Seed–Late Stage$4.4M – $214M
44 people
General Catalyst
San FranciscoPre-Seed–Late Stage$30M
41 people
Madrona Venture Group
SeattlePre-Seed–Growth$2M – $10M
69 people
8VC
AustinPre-Seed–Late Stage$500K – $50M
72 people
B Capital Group
Manhattan BeachPre-Seed–Late Stage$10M – $50M
99 people
Menlo Ventures
San FranciscoPre-Seed–Growth$1M – $20M
40 people
Kleiner Perkins
Menlo ParkPre-Seed–Late Stage$500K – $15M
48 people
BDC Fund Investments (Fund-of-Funds)
MontréalSeed–Growth
117 people
Frazier Life Sciences
Palo AltoSeed–Late Stage
72 people
Aju IB Invesment Corporation
SeoulSeed–Late Stage
Foresite Capital
LarkspurPre-Seed–Late Stage
59 people
Octopus Ventures
LondonPre-Seed–Late Stage$130K – $1.3M
87 people
Sofinnova Ventures
Menlo ParkSeed–Late Stage$100K – $15M
48 people
New Enterprise Associates (NEA)
Menlo ParkSeed–Late Stage$200K – $40M
71 people
Speedinvest
ViennaPre-Seed–Late Stage$5M – $30M
81 people
Oxford Science Enterprises
OxfordPre-Seed–Growth$63.5K – $31.8M
78 people
Related lists
Series C Investors & VC Firms (2751)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)Biotech Series A Investors & VC Firms (1596)Biotech Investors & VC Firms in United States (1039)Series C Investors & VC Firms in United States (906)Biotech Series B Investors & VC Firms (900)Biotech Pre-Seed Investors & VC Firms (896)Series C Investors & VC Firms in Global (852)Healthtech Series C Investors & VC Firms (771)
Data sourced from public filings and firms' own websites — see our methodology.


































.jpeg)

.jpg)


















































